{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-046845","form_type":"8-K","ticker":"NVCT","cik":"0001875558","company_name":"Nuvectis Pharma, Inc.","filed_at":"2025-05-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.333460+00:00","generated_at":"2026-05-22T02:17:18.333310+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Nuvectis Pharma establishes $60M ATM with Leerink Partners; terminates prior HC Wainwright program","bullets":["New ATM agreement with Leerink Partners to sell up to $60M of common stock; 3.0% commission on gross proceeds.","Prior ATM with H.C. Wainwright for up to $40M terminated; ~$18.6M had been sold under that program.","No costs or payments associated with termination of prior ATM.","Sales will be made as at-the-market offerings on Nasdaq subject to customary conditions.","Proceeds from any sales will be used for general corporate purposes as described in the prospectus supplement."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-046845","json":"https://secwatch.observer/filing/0001104659-25-046845.json","markdown":"https://secwatch.observer/filing/0001104659-25-046845.md","text":"https://secwatch.observer/filing/0001104659-25-046845.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925046845/0001104659-25-046845-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925046845/tm2514418d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T02:17:18.333310+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}